Skip to main content
MedaAdvisor Solution
  • About Us
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Careers
  • Solutions
    • Pharma
      • Vaccines
    • Pharmacy
    • Speciality
  • Resources
  • Investors
  • Contact Us

Medication Non-Adherence: A Persistent Global Crisis

Medication non-adherence is a significant healthcare challenge, with far-reaching implications for both patients and the pharmaceutical industry. Globally, it costs the industry an estimated $300 billion annually due to additional medical appointments, emergency department visits, and hospitalizations. In the United States alone, non-adherence contributes to over 125,000 preventable deaths each year.1

false https://www.medadvisorsolutions.com/hubfs/Best%20Practices%20for%20Building%20Advanced%20Medication%20Adherence%20Programs.pdf Download Now
true Best Practices for Building Advanced Medication Adherence Programs

Download Now
Insights

Best Practices for Building Advanced Medication Adherence Programs

  • By Admin
  • Jan 13, 2025

Best Practices for Building Advanced Medication Adherence Programs

X

Tell us about you. Learn more about us.

Medication Non-Adherence: A Persistent Global Crisis

Medication non-adherence is a significant healthcare challenge, with far-reaching implications for both patients and the pharmaceutical industry. Globally, it costs the industry an estimated $300 billion annually due to additional medical appointments, emergency department visits, and hospitalizations. In the United States alone, non-adherence contributes to over 125,000 preventable deaths each year.1

Insights
PREVIOUS POST
image

Can I Have Grapefruit with That? How AI Can Transform Pharmacy Patient Engagement

NEXT POST

Unlocking Growth for Mature Pharma Brands

image

Related Posts

Unlocking Growth for Mature Pharma Brands
Insights

Unlocking Growth for Mature Pharma Brands

Read More
Boosting Patient Adherence with Omnichannel Engagement for GLP-1s
Case Study

Boosting Patient Adherence with Omnichannel Engagement for GLP-1s

Client: Fortune 500 Life Sciences Manufacturer.

Read More
Powering long-term adherence for a PCSK9 inhibitor with predictive patient support
Case Study

Powering long-term adherence for a PCSK9 inhibitor with predictive patient support

For patients at high risk of cardiovascular events, PCSK9 inhibitors represent a critical...

Read More
Proven Results: In-Pharmacy Education Drives Awareness and Specialist Visits for Advanced Asthma Treatments
eBook,
Case Study

Proven Results: In-Pharmacy Education Drives Awareness and Specialist Visits for Advanced Asthma Treatments

Introduction: Empowering Patients to Manage Severe Asthma The Asthma Biologic in Pharmacy...

Read More
MedaAdvisor Solution
  • Home
  • About Us
  • Solutions
  • Resources
  • Investors
  • Careers
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
Medadvisors Solution
Iso Certified

©  2025 Medadvisor Solutions / All Rights Reserved